scispace - formally typeset
S

Suzy M. Sabry

Researcher at Alexandria University

Publications -  29
Citations -  363

Suzy M. Sabry is an academic researcher from Alexandria University. The author has contributed to research in topics: Fluorescence spectrometry & Hanging mercury drop electrode. The author has an hindex of 12, co-authored 27 publications receiving 346 citations.

Papers
More filters
Journal ArticleDOI

Study of stability of methotrexate in acidic solution spectrofluorimetric determination of methotrexate in pharmaceutical preparations through acid-catalyzed degradation reaction.

TL;DR: Spectrofluorimetric method for determination of methotrexate through measurement of its acid-degradation product, 4-amino-4-deoxy-10-methylpteroic acid (AMP), was developed and successfully applied for the analysis of MTX in pure drug and tablets dosage form.
Journal ArticleDOI

Determination of flufenamic and mefenamic acids in pharmaceutical preparations using organized media

TL;DR: In this article, the fluorescence properties of flufenamic (FF) and mefenamic (MF) acids were obtained in aqueous and binary anionic and non-ionic solvents with and without α-and β-cyclodextrins (CDs).
Journal ArticleDOI

Voltammetric, spectrofluorimetric and spectrophotometric methods to determine flufenamic acid.

TL;DR: Simple, rapid and sensitive voltammetric, spectrofluorimetric and spectrophotometric methods for determination of flufenamic acid (FF) in bulk powder and capsule dosage form were presented.
Journal ArticleDOI

Adsorptive stripping voltammetric assay of phenazopyridine hydrochloride in biological fluids and pharmaceutical preparations.

TL;DR: A sensitive method for the measurement of phenazopyridine hydrochloride (PAP) by differential pulse polarography (DPP) based on adsorptive stripping technique, using a hanging mercury drop electrode (HMDE) is described.
Journal ArticleDOI

Spectrofluorimetric determination of 2-aminopyridine as a potential impurity in piroxicam and tenoxicam within the pharmacopoeial limit.

TL;DR: Selective spectrofluorimetric determination of 2-AP in PX and TX, within or near the pharmacopoeial level, 0.2%, was developed, based on the measurement of the native fluorescence either in aqueous 0.1N sulfuric acid or in dioxane, for confirming purity of Px and TX in bulk and pharmaceutical preparations.